ai2 min read·Updated May 18, 2026·Fact-check: reviewed

SandboxAQ Bridges Quantitative Science and Conversational AI via Claude Integration

The Alphabet spinout is making its physics-grounded drug discovery tools accessible through a natural language interface, removing the need for specialized computing infrastructure.

BylineEditorial Desk··Updated May 18, 2026
Source context

Primary source: TechCrunch AI. Full source links and update notes are below.

Fast summary

Start here

  • SandboxAQ is integrating its Large Quantitative Models (LQMs) directly into Anthropic's Claude interface.
  • The integration allows researchers to run complex quantum chemistry and molecular simulations using natural language commands.
  • The initiative aims to reduce the technical barriers in drug discovery and materials science, targeting the $50 trillion 'quantitative economy'.
A visual representation of molecular simulation and digital drug discovery tools being used on a computer interface.

What happened

Alphabet spinout SandboxAQ has announced a partnership with Anthropic to integrate its specialized scientific models into the Claude AI platform. This collaboration brings proprietary "physics-grounded" simulations to a conversational interface, specifically targeting researchers in biopharma and advanced materials who may lack a deep background in computational infrastructure.

What's new in this update

Unlike previous iterations where users had to provide and manage their own digital infrastructure to run SandboxAQ’s models, this update places powerful drug discovery tools behind a frontier Large Language Model (LLM). For the first time, complex simulations of molecular dynamics and microkinetics can be accessed and manipulated via natural language, simplifying the workflow for experimental scientists.

Key details

The integration utilizes SandboxAQ's Large Quantitative Models (LQMs). These are trained on physical laws, scientific equations, and real-world lab data rather than text patterns. These models are designed to simulate how chemical reactions unfold at a molecular level, helping researchers predict the behavior of candidate molecules before they are ever synthesized in a physical laboratory.

Background and context

SandboxAQ was founded approximately five years ago as a spinout from Alphabet and is chaired by former Google CEO Eric Schmidt. The company, which has raised more than $950 million, focuses on the "quantitative economy." This sector spans biopharma, energy, and financial services, where precision modeling of physical properties and chemical reactions is a critical component of research and development.

What to watch next

The partnership aims to challenge competitors like Chai Discovery and Isomorphic Labs by prioritizing usability for non-computational researchers. Future developments will likely focus on expanding the library of quantitative models available within Claude to cover more specific areas of the $50 trillion industrial sector that SandboxAQ intends to transform.

Why it matters

This move lowers the barrier to entry for pharmaceutical and materials researchers, potentially accelerating discovery timelines by replacing specialized infrastructure with an intuitive AI interface.

Read next

Follow this story through the topic hub, more ai coverage, and the latest updates.

Weekly briefing

Get the week's key developments in one concise email.

Get a fast catch-up on the biggest stories, the context behind them, and the links worth your time.

Cadence

Weekly, for a quick catch-up

Coverage

AI, business, world, security, sports

Format

Clear takeaways and useful context

Request the briefing

Leave your email to open a prepared request and get on the list for the weekly briefing.

One concise email.·Weekly cadence.·Prefer RSS instead?

Author

E
Editorial Desk

See who assembled this story and follow more of their work.

Sources and methodology

SandboxAQDrug DiscoveryQuantum ChemistryAlphabetEric SchmidtBiotechnology